MICELLES FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
Composition comprising a polymeric micelle and an associated polynucleotide.
1 - 49 . (canceled)
50 . A composition comprising a polymeric micelle and a polynucleotide associated with the micelle, the micelle comprising a plurality of block copolymers, each block copolymer comprising a hydrophilic block and a hydrophobic block, the plurality of block copolymers associating such that the micelle is stable in an aqueous medium at about neutral pH,
(a) the micelle further having two or more characteristics selected from:
(i) the micelle comprising from about 10 to about 100 of the block copolymers per micelle,
(ii) a critical micelle concentration, CMC, ranging from about 0.21 μg/mL to about 20 μg/mL,
(iii) spontaneous micelle assembly in the absence of nucleic acid;
(iv) a weight average molecular weight of about 0.5×106 to about 3.6×106 dalton;
(v) a particle size of about 5 nm to about 500 nm; and
(b) the block copolymers having one or more characteristic selected from:
(i) a ratio of a number-average molecular weight, Mn, of the hydrophilic block to the hydrophobic block, ranging from about 1:1 to about 1:10, and
(ii) a polydispersity index of about 1.0 to about 2.0.
51 . The composition of claim 50 , wherein the micelle has all of the characteristics of subparagraphs (i), (ii), (iii) and (iv) thereof.
52 . The composition of claim 50 , wherein the block copolymer has a ratio of a number-average molecular weight, Mn, of the hydrophilic block to the hydrophobic block, ranging from about 1:1.5 to about 1:6.
53 . The composition of claim 50 , wherein the micelle comprises about 10 to about 100 of the block copolymers per micelle.
54 . The composition of claim 50 , wherein the micelle is has a critical micelle concentration, CMC, of about 0.2 μg/mL to about 20 μg/mL.
55 . The composition of claim 50 , wherein the block copolymer has a ratio of a number-average molecular weight, Mn, of the hydrophilic block to the hydrophobic block, ranging from about 1:1.5 to about 1:6; and the micelle
(i) comprises about 20 to about 60 of the block copolymers per micelle, and
(ii) has a critical micelle concentration, CMC, of about 0.5 μg/mL to about 10 μg/mL.
56 . The composition of claim 50 , wherein the block copolymers have a polydispersity index of about 1.0 to about 1.7.
57 . The composition of claim 50 , wherein the micelle has an weight average molecular weight, Mw, of about 0.75×106 to about 2.0×106.
58 . The composition of claim 50 , wherein the micelle comprises a block copolymer comprising a plurality of cationic monomeric units, the cationic species in the hydrophilic block being in ionic association with the polynucleotide.
59 . The composition of claim 58 , wherein the cationic monomeric units are residues of cationic monomers, non-charged Brønsted base monomers, or a combination thereof.
60 . The composition of claim 50 , wherein the polynucleotide is not in the core of the micelle.
61 . The composition of claim 50 , wherein the micelle comprises a block copolymer comprising a plurality of anionic monomeric units in the hydrophilic block and/or the hydrophobic block.
62 . The composition of claim 50 , wherein the micelle comprises a block copolymer comprising a plurality of uncharged monomeric units in the hydrophilic block and/or the hydrophobic block.
63 . The composition of claim 50 , comprising one or more polynucleotides covalently coupled to one or more of the plurality of block copolymers.
64 . The composition of claim 63 , wherein the polynucleotide is an siRNA.
65 . The composition of claim 50 , wherein the micelle comprises a block copolymer comprising a plurality of monomeric units having a protonatable anionic species and a plurality of hydrophobic species.
66 . The composition of claim 65 , wherein the monomeric units are residues of anionic monomers, non-charged Brønsted acid monomers, or a combination thereof.
67 . The composition of claim 50 , wherein the micelle comprises a block copolymer comprising a plurality of monomeric units derived from a polymerizable monomer having a hydrophobic species.
68 . The composition of claim 50 , wherein the one or more of the block copolymers is a membrane destabilizing block copolymer.
69 . The composition of claim 50 , wherein the number of polynucleotides associated with each micelle is about 1 to about 10,000.
70 . A method for intracellular delivery of a polynucleotide, comprising contacting a cell with the composition of claim 50 .